Increased Coagulation Activity
- Increased Coagulation Activity
- Accession Number
Drug Drug Description Prothrombin A coagulation factor used for emergency reversal of vitamin K antagonist therapy. Factor XIII (human) A purified form of Factor XIII that is used to prevent and treat surgical bleeding in patients with a Factor XIII deficiency. Coagulation Factor IX Human A coagulation factor used to treat hemophilia B or factor IX hemophilia. Coagulation Factor IX (Recombinant) A form of recombinant human coagulation Factor IX used to treat hemophilia B. Coagulation factor VII human A coagulation factor used to treat bleeding disorders such as hemophilia and Glanzmann's thrombasthenia. Coagulation factor X human A coagulation factor used to treat Factor X deficiency to control bleeding. Antihemophilic factor, human recombinant A form of recombinant coagulation Factor VIII used to treat hemophilia A, von Willebrand disease, and Factor XIII deficiency. Fibrinogen human A hemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. Von Willebrand factor human A blood clotting factor used to manage bleeding episodes in von Willebrand disease and hemophilia A. Antihemophilic factor human A Factor VIII replacement therapy used to treat hemophilia A.
- Drugs & Drug Targets